Platelet-to-Lymphocyte Ratio Multiplied by the Cytokeratin-19 Fragment Level as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Platelet-to-Lymphocyte Ratio Multiplied by the Cytokeratin-19 Fragment Level as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma

Published:2021 Issue:3 Volume:64 Page:249-259
ISSN:1346-8049
Container-title:Yonago Acta Medica
language:en
Short-container-title:Yonago Acta Med.

Author:

Shishido Yuji¹,Matsunaga Tomoyuki¹,Sawata Shohei¹,Makinoya Masahiro¹,Miyauchi Wataru¹,Miyatani Kozo¹,Uejima Chihiro¹,Morimoto Masaki¹,Murakami Yuki¹,Hanaki Takehiko¹,Kihara Kyoichi¹,Yamamoto Manabu¹,Tokuyasu Naruo¹,Takano Shuichi¹,Sakamoto Teruhisa¹,Saito Hiroaki²,Hasegawa Toshimichi¹,Fujiwara Yoshiyuki¹

Affiliation:

1. Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan

2. Department of Surgery, Japanese Red Cross Tottori Hospital, Tottori 680-8517, Japan

Publisher

Tottori University Faculty of Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/yam/64/3/64_2021.08.003/_pdf

Reference32 articles.

1. 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90. PMID:21296855, DOI:10.3322/caac.20107

2. 2. Watanabe M, Tachimori Y, Oyama T, Toh Y, Matsubara H, Ueno M, et al.; Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Comprehensive registry of esophageal cancer in Japan, 2013. Esophagus. 2021;18:1-24. PMID:33047261, DOI:10.1007/s10388-020-00785-y

3. 3. Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68-74. PMID:21879261, DOI:10.1245/s10434-011-2049-9

4. 4. Matsuda S, Kawakubo H, Okamura A, Takahashi K, Toihata T, Takemura R, et al. Distribution of Residual Disease and Recurrence Patterns in Pathological Responders After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Ann Surg. 2020 Oct 16. Online ahead of print. PMID:33074909, DOI:10.1097/SLA.0000000000004436

5. 5. Okamura A, Matsuda S, Mayanagi S, Kanamori J, Imamura Y, Irino T, et al. Clinical significance of pretherapeutic serum squamous cell carcinoma antigen level in patients with neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Ann Surg Oncol. 2021;28:1209-16. PMID:32524457, DOI:10.1245/s10434-020-08716-y

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential and application of abortive transcripts as a novel molecular marker of cancers;World Journal of Experimental Medicine;2024-06-20